Early intensive therapy may delay MS progression

Early aggressive therapy for multiple sclerosis is associated with improved long-term outcomes compared with an escalation approach, a study in JAMA Neurology has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research